Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7.94M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.79M
-
Shares change
-
+1.79M
-
Total reported value, excl. options
-
$31.1M
-
Value change
-
+$31.1M
-
Number of buys
-
28
-
Price
-
$17.41
Significant Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q1 2019
28 filings reported holding XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share as of Q1 2019.
X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.79M shares
of 7.94M outstanding shares and own 22.53% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (333K shares), ORBIMED ADVISORS LLC (311K shares), Polaris Venture Management Co. V, L.L.C. (311K shares), SV Health Investors, LLC (311K shares), Cormorant Asset Management, LP (253K shares), VANGUARD GROUP INC (86.3K shares), FEDERATED INVESTORS INC /PA/ (68.6K shares), BlackRock Inc. (39.9K shares), First Eagle Investment Management, LLC (20.7K shares), and STATE STREET CORP (17.7K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.